DALLAS--(BUSINESS WIRE)--Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced ...

The start-up Colossal Biosciences aims to use gene-editing technology to bring back the woolly mammoth and other extinct species. Recently, the company achieved major milestones: last year, they ...

Scientists have made a leap in genetic engineering by pushing elephant cells into an embryonic-like state. This marks a major step toward recreating traits of the extinct woolly mammoth, offering new ...

When the elevator doors part on the second floor of a two-story brick and glass building in an office park on the outskirts of downtown Dallas, it feels like a portal opening to a different world. The ...

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly mammoth from extinction. In a preprint paper published on March 4, scientists at ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. Colossal Biosciences is now valued at over $10 billion and ...

On my recent visit to Colossal Biosciences’ new Dallas headquarters, still under construction ahead of its October opening, I asked for the latest update on one of the company’s most ambitious ...

Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...

Colossal Biosciences CEO Ben Lamm speaking at SXSW in Austin, Texas on March 9. Amy E. Price/SXSW Conference & Festivals via Getty Images The biotech aspect, which involves genetically engineering ...